BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'E3 ubiquitin-protein ligase Mdm2' and Ligand = 'BDBM135425'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM135425
PNG
(US8846657, 16.1)
Show SMILES CC([C@H]1CC[C@H](C)CC1)n1c(nc2cc(nc(-c3cncc(Cl)c3)c12)-c1noc(=O)[nH]1)N1CCN(C[C@H]1C)C(=O)C1(F)CC1 |r,wU:2.1,wD:5.5,36.42,(-1.36,-3.19,;-.27,-2.1,;1.22,-2.5,;2.31,-1.41,;3.8,-1.81,;4.19,-3.29,;5.68,-3.69,;3.11,-4.38,;1.62,-3.98,;-.67,-.61,;.24,.64,;-.67,1.88,;-2.13,1.41,;-3.47,2.18,;-4.8,1.41,;-4.8,-.13,;-3.47,-.9,;-3.47,-2.44,;-2.13,-3.21,;-2.13,-4.75,;-3.47,-5.52,;-4.8,-4.75,;-6.13,-5.52,;-4.8,-3.21,;-2.13,-.13,;-6.13,2.18,;-7.6,1.7,;-8.5,2.95,;-7.6,4.19,;-8.37,5.52,;-6.13,3.72,;1.78,.64,;2.55,-.7,;4.09,-.7,;4.86,.64,;4.09,1.97,;2.55,1.97,;1.78,3.3,;6.4,.64,;7.17,1.97,;7.17,-.7,;8.26,.39,;7.17,-2.24,;8.5,-1.47,)|
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 1n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...


US Patent US8962611 (2015)


BindingDB Entry DOI: 10.7270/Q28G8JDZ
More data for this
Ligand-Target Pair
E3 ubiquitin-protein ligase Mdm2


(Homo sapiens (Human))
BDBM135425
PNG
(US8846657, 16.1)
Show SMILES CC([C@H]1CC[C@H](C)CC1)n1c(nc2cc(nc(-c3cncc(Cl)c3)c12)-c1noc(=O)[nH]1)N1CCN(C[C@H]1C)C(=O)C1(F)CC1 |r,wU:2.1,wD:5.5,36.42,(-1.36,-3.19,;-.27,-2.1,;1.22,-2.5,;2.31,-1.41,;3.8,-1.81,;4.19,-3.29,;5.68,-3.69,;3.11,-4.38,;1.62,-3.98,;-.67,-.61,;.24,.64,;-.67,1.88,;-2.13,1.41,;-3.47,2.18,;-4.8,1.41,;-4.8,-.13,;-3.47,-.9,;-3.47,-2.44,;-2.13,-3.21,;-2.13,-4.75,;-3.47,-5.52,;-4.8,-4.75,;-6.13,-5.52,;-4.8,-3.21,;-2.13,-.13,;-6.13,2.18,;-7.6,1.7,;-8.5,2.95,;-7.6,4.19,;-8.37,5.52,;-6.13,3.72,;1.78,.64,;2.55,-.7,;4.09,-.7,;4.86,.64,;4.09,1.97,;2.55,1.97,;1.78,3.3,;6.4,.64,;7.17,1.97,;7.17,-.7,;8.26,.39,;7.17,-2.24,;8.5,-1.47,)|
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 1n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
Methods: An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 wi...


US Patent US8846657 (2014)


BindingDB Entry DOI: 10.7270/Q29C6W3K
More data for this
Ligand-Target Pair